<?xml version="1.0" encoding="UTF-8"?>
<p>The criteria for eligibility of CP donors may vary between countries. According to the FDA, individuals who meet the following criteria can be a CP donor
 <xref rid="jca21806-bib-0016" ref-type="ref">
  <sup>16</sup>
 </xref>:
 <list list-type="order" id="jca21806-list-0001">
  <list-item id="jca21806-li-0001">
   <p>Recovered from COVID‐19, blood donor tests were done and suitable for donation;</p>
  </list-item>
  <list-item id="jca21806-li-0002">
   <p>Evidence of COVID‐19 documented by a laboratory test either by a diagnostic test (eg, nasopharyngeal swab) at the time of illness, or a positive serological test for SARS‐CoV‐2 antibodies after recovery, if prior diagnostic testing was not performed at the time COVID‐19 was suspected.</p>
  </list-item>
  <list-item id="jca21806-li-0003">
   <p>Complete resolution of symptoms at least 14 days prior to donation.</p>
  </list-item>
  <list-item id="jca21806-li-0004">
   <p>Male donors, or female donors who have not been pregnant, or female donors who have been tested since their most recent pregnancy and results interpreted as negative for HLA antibodies.</p>
  </list-item>
  <list-item id="jca21806-li-0005">
   <p>When measurement of neutralizing antibody titers is available, neutralizing antibody titers of at least 1:160 is recommended. A titer of 1:80 may be considered acceptable if an alternative matched unit is not available.</p>
  </list-item>
 </list>
</p>
